TY - JOUR T1 - Correction to “CXL146, a Novel 4<em>H</em>-Chromene Derivative, Targets GRP78 to Selectively Eliminate Multidrug-Resistant Cancer Cells” JF - Molecular Pharmacology JO - Mol Pharmacol SP - 182 LP - 182 DO - 10.1124/molpharm.119.000110 VL - 98 IS - 2 A2 - , Y1 - 2020/08/01 UR - http://molpharm.aspetjournals.org/content/98/2/182.abstract N2 - ER -